Connection

Jacques Izopet to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Drug Administration Schedule.
Jacques Izopet
Connection Strength
0.108
Drug Administration Schedule
  1. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Antivir Ther. 2008; 13(4):537-45.
    View in: PubMed
    Score: 0.053
  2. Should 12- or 24-week post-ribavirin follow-up be considered to define sustained virological response in transplant patients treated for chronic hepatitis E virus infection? Transpl Infect Dis. 2019 06; 21(3):e13065.
    View in: PubMed
    Score: 0.029
  3. Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial. J Antimicrob Chemother. 2018 03 01; 73(3):738-747.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.